Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Verastem
VSTM
$604M
| $1.56M | ﹤0.01% |
201,845
+33,470
| +20% | +$298K |
|
3077
TPG
TPG
$8.86B
| $1.55M | ﹤0.01% |
24,329
-48,962
| -67% | -$2.89M |
|
3078
Select Water Solutions
WTTR
$2.63B
| $1.55M | ﹤0.01% |
147,581
+857
| +0.6% | +$9.24K |
|
3079
BioLife Solutions
BLFS
$1.72B
| $1.55M | ﹤0.01% |
64,094
+9,792
| +18% | +$256K |
|
3080
Kyverna Therapeutics
KYTX
$500M
| $1.55M | ﹤0.01% |
164,668
+88,477
| +116% | +$657K |
|
3081
First Business Financial Services
FBIZ
$601M
| $1.55M | ﹤0.01% |
28,454
+1,665
| +6% | +$87.1K |
|
3082
Tactile Systems Technology
TCMD
$537M
| $1.54M | ﹤0.01% |
53,235
+11,037
| +26% | +$245K |
|
|
BRRWW
3083
ProCap Financial Inc
BRRWW
$2.47M
| $1.54M | ﹤0.01% |
2,202,264
+537,434
| +32% | +$470K |
|
|
NNE
3084
Nano Nuclear Energy
NNE
$1.1B
| $1.54M | ﹤0.01% |
64,149
+19,778
| +45% | +$757K |
|
|
QXO.PRB
3085
QXO Inc 5.50% Series B Preferred Stock
QXO.PRB
$507M
| $1.54M | ﹤0.01% |
27,895
-22,105
| -44% | -$1.22M |
|
|
PSIX
3086
Power Solutions International
PSIX
$947M
| $1.54M | ﹤0.01% |
26,874
+16,394
| +156% | +$1.17M |
|
3087
Southern First Bancshares
SFST
$612M
| $1.54M | ﹤0.01% |
29,800
+1,151
| +4% | +$55.2K |
|
3088
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $1.53M | ﹤0.01% |
28,512
+22,911
| +409% | +$1.24M |
|
3089
Utz Brands
UTZ
$1.25B
| $1.53M | ﹤0.01% |
147,491
-111,169
| -43% | -$1.2M |
|
3090
Heritage Financial
HFWA
$1.23B
| $1.53M | ﹤0.01% |
64,554
+14,429
| +29% | +$340K |
|
|
RYZ
3091
Ryerson Holding Corp
RYZ
$1.5B
| $1.53M | ﹤0.01% |
60,670
+2,973
| +5% | +$68.4K |
|
3092
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.29B
| $1.52M | ﹤0.01% |
33,802
-2,477
| -7% | -$113K |
|
3093
Keros Therapeutics
KROS
$211M
| $1.52M | ﹤0.01% |
74,726
-24,374
| -25% | -$428K |
|
3094
Hanmi Financial
HAFC
$963M
| $1.52M | ﹤0.01% |
56,249
+11,703
| +26% | +$313K |
|
|
FVR
3095
FrontView REIT
FVR
$487M
| $1.52M | ﹤0.01% |
102,898
-10,458
| -9% | -$150K |
|
3096
Liberty Latin America Class C
LILAK
$1.65B
| $1.52M | ﹤0.01% |
223,920
-127,594
| -36% | -$954K |
|
3097
Immuneering
IMRX
$336M
| $1.52M | ﹤0.01% |
230,726
+208,608
| +943% | +$1.34M |
|
3098
Mid Penn Bancorp
MPB
$971M
| $1.52M | ﹤0.01% |
48,931
+13,917
| +40% | +$411K |
|
3099
BJ's Restaurants
BJRI
$1.42B
| $1.51M | ﹤0.01% |
38,201
+2,593
| +7% | +$92.1K |
|
|
SMA
3100
SmartStop Self Storage REIT
SMA
$1.9B
| $1.5M | ﹤0.01% |
48,626
-11,617
| -19% | -$393K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.